A small tool to view real-world ActivityPub objects as JSON! Enter a URL
or username from Mastodon or a similar service below, and we'll send a
request with
the right
Accept
header
to the server to view the underlying object.
{
"@context": "https://www.w3.org/ns/activitystreams",
"type": "OrderedCollectionPage",
"orderedItems": [
{
"type": "Create",
"actor": "https://www.minds.com/api/activitypub/users/1152744141386424338",
"object": {
"type": "Note",
"id": "https://www.minds.com/api/activitypub/users/1152744141386424338/entities/urn:activity:1196137264780681216",
"attributedTo": "https://www.minds.com/api/activitypub/users/1152744141386424338",
"content": "<a href=\"https://greenwald.substack.com/p/how-silicon-valley-in-a-show-of-monopolistic\" target=\"_blank\">https://greenwald.substack.com/p/how-silicon-valley-in-a-show-of-monopolistic</a><br /><br />Quote: \"How Silicon Valley, in a Show of Monopolistic Force, Destroyed Parler<br /><br />In the last three months, tech giants have censored political speech and journalism to manipulate U.S. politics, while liberals, with virtual unanimity, have cheered.\"<br /><br />Glenn Greenwald<br />",
"to": [
"https://www.w3.org/ns/activitystreams#Public"
],
"cc": [
"https://www.minds.com/api/activitypub/users/1152744141386424338/followers"
],
"tag": [],
"url": "https://www.minds.com/newsfeed/1196137264780681216",
"published": "2021-01-13T17:02:27+00:00",
"source": {
"content": "https://greenwald.substack.com/p/how-silicon-valley-in-a-show-of-monopolistic\n\nQuote: \"How Silicon Valley, in a Show of Monopolistic Force, Destroyed Parler\n\nIn the last three months, tech giants have censored political speech and journalism to manipulate U.S. politics, while liberals, with virtual unanimity, have cheered.\"\n\nGlenn Greenwald\n",
"mediaType": "text/plain"
}
},
"id": "https://www.minds.com/api/activitypub/users/1152744141386424338/entities/urn:activity:1196137264780681216/activity"
},
{
"type": "Create",
"actor": "https://www.minds.com/api/activitypub/users/1152744141386424338",
"object": {
"type": "Note",
"id": "https://www.minds.com/api/activitypub/users/1152744141386424338/entities/urn:activity:1195493168018190336",
"attributedTo": "https://www.minds.com/api/activitypub/users/1152744141386424338",
"content": "<a href=\"https://nationalfile.com/parler-sues-amazon-over-ban-from-aws-servers-says-theyre-colluding-with-twitter-leaked-emails-to-buzzfeed/?utm_source=feedly&utm_medium=rss&utm_campaign=parler-sues-amazon-over-ban-from-aws-servers-says-theyre-colluding-with-twitter-leaked-emails-to-buzzfeed\" target=\"_blank\">https://nationalfile.com/parler-sues-amazon-over-ban-from-aws-servers-says-theyre-colluding-with-twitter-leaked-emails-to-buzzfeed/?utm_source=feedly&utm_medium=rss&utm_campaign=parler-sues-amazon-over-ban-from-aws-servers-says-theyre-colluding-with-twitter-leaked-emails-to-buzzfeed</a><br /><br />They had been promised at least a 30 day termination notice in their original contract. Quote: \"However, the lawsuit reveals that the story containing the email from AWS was posted to Buzzfeed an hour before it was actually received by Peikoff or anybody else on the Parler team. The lawsuit also notes that “the allegations contained in the letter it leaked to the press was not able to find and remove content that encouraged violence was false,” as Parler removed all the content AWS asked them to.<br /><br />“AWS sought to defame Parler nonetheless,” the lawsuit said. “AWS’s false claims have made Parler a pariah.” The supposed violent content posted on Parler, that the site swiftly removed, was nothing compared to what is posted on Twitter by the left every day. On the same day that AWS took action against Parler, “Hang Mike Pence” trended number 1 on Twitter. “AWS has no plans… to suspend Twitter’s account,” the lawsuit notes.<br /><br />You can read the full lawsuit below: \"",
"to": [
"https://www.w3.org/ns/activitystreams#Public"
],
"cc": [
"https://www.minds.com/api/activitypub/users/1152744141386424338/followers"
],
"tag": [],
"url": "https://www.minds.com/newsfeed/1195493168018190336",
"published": "2021-01-11T22:23:02+00:00",
"source": {
"content": "https://nationalfile.com/parler-sues-amazon-over-ban-from-aws-servers-says-theyre-colluding-with-twitter-leaked-emails-to-buzzfeed/?utm_source=feedly&utm_medium=rss&utm_campaign=parler-sues-amazon-over-ban-from-aws-servers-says-theyre-colluding-with-twitter-leaked-emails-to-buzzfeed\n\nThey had been promised at least a 30 day termination notice in their original contract. Quote: \"However, the lawsuit reveals that the story containing the email from AWS was posted to Buzzfeed an hour before it was actually received by Peikoff or anybody else on the Parler team. The lawsuit also notes that “the allegations contained in the letter it leaked to the press was not able to find and remove content that encouraged violence was false,” as Parler removed all the content AWS asked them to.\n\n“AWS sought to defame Parler nonetheless,” the lawsuit said. “AWS’s false claims have made Parler a pariah.” The supposed violent content posted on Parler, that the site swiftly removed, was nothing compared to what is posted on Twitter by the left every day. On the same day that AWS took action against Parler, “Hang Mike Pence” trended number 1 on Twitter. “AWS has no plans… to suspend Twitter’s account,” the lawsuit notes.\n\nYou can read the full lawsuit below: \"",
"mediaType": "text/plain"
}
},
"id": "https://www.minds.com/api/activitypub/users/1152744141386424338/entities/urn:activity:1195493168018190336/activity"
},
{
"type": "Create",
"actor": "https://www.minds.com/api/activitypub/users/1152744141386424338",
"object": {
"type": "Note",
"id": "https://www.minds.com/api/activitypub/users/1152744141386424338/entities/urn:activity:1195488604399026176",
"attributedTo": "https://www.minds.com/api/activitypub/users/1152744141386424338",
"content": "<a href=\"https://nationalfile.com/big-tech-exodus-gab-reportedly-receiving-thousands-of-resumes-from-silicon-valley-employees-as-facebook-twitter-stock-prices/?utm_source=feedly&utm_medium=rss&utm_campaign=big-tech-exodus-gab-reportedly-receiving-thousands-of-resumes-from-silicon-valley-employees-as-facebook-twitter-stock-prices\" target=\"_blank\">https://nationalfile.com/big-tech-exodus-gab-reportedly-receiving-thousands-of-resumes-from-silicon-valley-employees-as-facebook-twitter-stock-prices/?utm_source=feedly&utm_medium=rss&utm_campaign=big-tech-exodus-gab-reportedly-receiving-thousands-of-resumes-from-silicon-valley-employees-as-facebook-twitter-stock-prices</a><br /><br />Quote: \"Free speech social media platform Gab.com is reportedly receiving requests from “thousands of people” employed in the Silicon valley tech industry as the website explodes in popularity, amidst the latest wave of censorious new policies deployed by fringe-left executives at Big Tech monopolies such as Facebook and Twitter.<br />The official Gab Twitter account first reported over the weekend that the company was receiving requests for employment from large numbers of employees in the tech industry:<br /><br />“Silicon Valley should see our inbox right now. Looks like half of their employees want to leave and come work for Gab. Panic in SV!” \"",
"to": [
"https://www.w3.org/ns/activitystreams#Public"
],
"cc": [
"https://www.minds.com/api/activitypub/users/1152744141386424338/followers"
],
"tag": [],
"url": "https://www.minds.com/newsfeed/1195488604399026176",
"published": "2021-01-11T22:04:54+00:00",
"source": {
"content": "https://nationalfile.com/big-tech-exodus-gab-reportedly-receiving-thousands-of-resumes-from-silicon-valley-employees-as-facebook-twitter-stock-prices/?utm_source=feedly&utm_medium=rss&utm_campaign=big-tech-exodus-gab-reportedly-receiving-thousands-of-resumes-from-silicon-valley-employees-as-facebook-twitter-stock-prices\n\nQuote: \"Free speech social media platform Gab.com is reportedly receiving requests from “thousands of people” employed in the Silicon valley tech industry as the website explodes in popularity, amidst the latest wave of censorious new policies deployed by fringe-left executives at Big Tech monopolies such as Facebook and Twitter.\nThe official Gab Twitter account first reported over the weekend that the company was receiving requests for employment from large numbers of employees in the tech industry:\n\n“Silicon Valley should see our inbox right now. Looks like half of their employees want to leave and come work for Gab. Panic in SV!” \"",
"mediaType": "text/plain"
}
},
"id": "https://www.minds.com/api/activitypub/users/1152744141386424338/entities/urn:activity:1195488604399026176/activity"
},
{
"type": "Create",
"actor": "https://www.minds.com/api/activitypub/users/1152744141386424338",
"object": {
"type": "Note",
"id": "https://www.minds.com/api/activitypub/users/1152744141386424338/entities/urn:activity:1172317068084219904",
"attributedTo": "https://www.minds.com/api/activitypub/users/1152744141386424338",
"content": "Election Fraud Evidence Piles Up <a href=\"https://www.lewrockwell.com/lrc-blog/election-fraud-evidence-piles-up/\" target=\"_blank\">https://www.lewrockwell.com/lrc-blog/election-fraud-evidence-piles-up/</a><br /><br />Set of many links<br />",
"to": [
"https://www.w3.org/ns/activitystreams#Public"
],
"cc": [
"https://www.minds.com/api/activitypub/users/1152744141386424338/followers"
],
"tag": [],
"url": "https://www.minds.com/newsfeed/1172317068084219904",
"published": "2020-11-08T23:29:29+00:00",
"source": {
"content": "Election Fraud Evidence Piles Up https://www.lewrockwell.com/lrc-blog/election-fraud-evidence-piles-up/\n\nSet of many links\n",
"mediaType": "text/plain"
}
},
"id": "https://www.minds.com/api/activitypub/users/1152744141386424338/entities/urn:activity:1172317068084219904/activity"
},
{
"type": "Create",
"actor": "https://www.minds.com/api/activitypub/users/1152744141386424338",
"object": {
"type": "Note",
"id": "https://www.minds.com/api/activitypub/users/1152744141386424338/entities/urn:activity:1171608028541296640",
"attributedTo": "https://www.minds.com/api/activitypub/users/1152744141386424338",
"content": "<a href=\"https://www.newswise.com/articles/hydroxychloroquine-not-linked-to-longer-heart-rhythm-intervals-in-rheumatoid-arthritis-or-lupus-patients#.X6Wgxiz0ZGo.twitter\" target=\"_blank\">https://www.newswise.com/articles/hydroxychloroquine-not-linked-to-longer-heart-rhythm-intervals-in-rheumatoid-arthritis-or-lupus-patients#.X6Wgxiz0ZGo.twitter</a>",
"to": [
"https://www.w3.org/ns/activitystreams#Public"
],
"cc": [
"https://www.minds.com/api/activitypub/users/1152744141386424338/followers"
],
"tag": [],
"url": "https://www.minds.com/newsfeed/1171608028541296640",
"published": "2020-11-07T00:32:01+00:00",
"source": {
"content": "https://www.newswise.com/articles/hydroxychloroquine-not-linked-to-longer-heart-rhythm-intervals-in-rheumatoid-arthritis-or-lupus-patients#.X6Wgxiz0ZGo.twitter",
"mediaType": "text/plain"
}
},
"id": "https://www.minds.com/api/activitypub/users/1152744141386424338/entities/urn:activity:1171608028541296640/activity"
},
{
"type": "Create",
"actor": "https://www.minds.com/api/activitypub/users/1152744141386424338",
"object": {
"type": "Note",
"id": "https://www.minds.com/api/activitypub/users/1152744141386424338/entities/urn:activity:1167843742972305408",
"attributedTo": "https://www.minds.com/api/activitypub/users/1152744141386424338",
"content": "A new meta-analysis overview of Covid-19 treatments. This page focused on Hydroxychloroquine (HCQ). Quote:<br /><br />•HCQ is effective for COVID-19. The probability that an ineffective treatment generated results as positive as the 121 studies to date is estimated to be 1 in 27 million (p = 0.000000037).<br /><br />•Early treatment is most successful, with 100% of studies reporting a positive effect and an estimated reduction of 63% in the effect measured (death, hospitalization, etc.) using a random effects meta-analysis, RR 0.37 [0.29-0.48].<br /><br />•100% of Randomized Controlled Trials (RCTs) for early, PrEP, or PEP treatment report positive effects, the probability of this happening for an ineffective treatment is 0.002.<br /><br />•There is evidence of bias towards publishing negative results. Significantly more retrospective studies report negative results compared to prospective studies, p = 0.04.<br /><br />•Significantly more studies in North America report negative results compared to the rest of the world, p = 0.003.<br /><br /><a href=\"https://hcqmeta.com/\" target=\"_blank\">https://hcqmeta.com/</a><br /><br />Remember, if you are interested in getting a prescription for HCQ, it is very inexpensive, and this is what you need to do.<br /><br />Obtained from a Twitter Tweet by Dr. Simone Gold, M.D.), quote: \"UPDATE: We have officially launched a resource to connect patients across the country with physicians & pharmacists who are HCQ knowledgeable!<br /><br />To access:<br />Go to: <a href=\"http://AFLDS.com\" target=\"_blank\">http://AFLDS.com</a><br />Click on: HCQ<br />Click on: your state of residence<br />Scroll down to: Speak to an MD",
"to": [
"https://www.w3.org/ns/activitystreams#Public"
],
"cc": [
"https://www.minds.com/api/activitypub/users/1152744141386424338/followers"
],
"tag": [],
"url": "https://www.minds.com/newsfeed/1167843742972305408",
"published": "2020-10-27T15:14:05+00:00",
"source": {
"content": "A new meta-analysis overview of Covid-19 treatments. This page focused on Hydroxychloroquine (HCQ). Quote:\n\n•HCQ is effective for COVID-19. The probability that an ineffective treatment generated results as positive as the 121 studies to date is estimated to be 1 in 27 million (p = 0.000000037).\n\n•Early treatment is most successful, with 100% of studies reporting a positive effect and an estimated reduction of 63% in the effect measured (death, hospitalization, etc.) using a random effects meta-analysis, RR 0.37 [0.29-0.48].\n\n•100% of Randomized Controlled Trials (RCTs) for early, PrEP, or PEP treatment report positive effects, the probability of this happening for an ineffective treatment is 0.002.\n\n•There is evidence of bias towards publishing negative results. Significantly more retrospective studies report negative results compared to prospective studies, p = 0.04.\n\n•Significantly more studies in North America report negative results compared to the rest of the world, p = 0.003.\n\nhttps://hcqmeta.com/\n\nRemember, if you are interested in getting a prescription for HCQ, it is very inexpensive, and this is what you need to do.\n\nObtained from a Twitter Tweet by Dr. Simone Gold, M.D.), quote: \"UPDATE: We have officially launched a resource to connect patients across the country with physicians & pharmacists who are HCQ knowledgeable!\n\nTo access:\nGo to: http://AFLDS.com\nClick on: HCQ\nClick on: your state of residence\nScroll down to: Speak to an MD",
"mediaType": "text/plain"
}
},
"id": "https://www.minds.com/api/activitypub/users/1152744141386424338/entities/urn:activity:1167843742972305408/activity"
},
{
"type": "Create",
"actor": "https://www.minds.com/api/activitypub/users/1152744141386424338",
"object": {
"type": "Note",
"id": "https://www.minds.com/api/activitypub/users/1152744141386424338/entities/urn:activity:1167843695489552384",
"attributedTo": "https://www.minds.com/api/activitypub/users/1152744141386424338",
"content": "A new meta-analysis overview of Covid-19 treatments. This page focused on Hydroxychloroquine (HCQ). Quote:<br /><br />•HCQ is effective for COVID-19. The probability that an ineffective treatment generated results as positive as the 121 studies to date is estimated to be 1 in 27 million (p = 0.000000037).<br /><br />•Early treatment is most successful, with 100% of studies reporting a positive effect and an estimated reduction of 63% in the effect measured (death, hospitalization, etc.) using a random effects meta-analysis, RR 0.37 [0.29-0.48].<br /><br />•100% of Randomized Controlled Trials (RCTs) for early, PrEP, or PEP treatment report positive effects, the probability of this happening for an ineffective treatment is 0.002.<br /><br />•There is evidence of bias towards publishing negative results. Significantly more retrospective studies report negative results compared to prospective studies, p = 0.04.<br /><br />•Significantly more studies in North America report negative results compared to the rest of the world, p = 0.003.<br /><br /><a href=\"https://hcqmeta.com/\" target=\"_blank\">https://hcqmeta.com/</a><br /><br />Remember, if you are interested in getting a prescription for HCQ, it is very inexpensive, and this is what you need to do.<br /><br />Obtained from a Twitter Tweet by Dr. Simone Gold, M.D.), quote: \"UPDATE: We have officially launched a resource to connect patients across the country with physicians & pharmacists who are HCQ knowledgeable!<br /><br />To access:<br />Go to: <a href=\"http://AFLDS.com\" target=\"_blank\">http://AFLDS.com</a><br />Click on: HCQ<br />Click on: your state of residence<br />Scroll down to: Speak to an MD",
"to": [
"https://www.w3.org/ns/activitystreams#Public"
],
"cc": [
"https://www.minds.com/api/activitypub/users/1152744141386424338/followers"
],
"tag": [],
"url": "https://www.minds.com/newsfeed/1167843695489552384",
"published": "2020-10-27T15:13:54+00:00",
"source": {
"content": "A new meta-analysis overview of Covid-19 treatments. This page focused on Hydroxychloroquine (HCQ). Quote:\n\n•HCQ is effective for COVID-19. The probability that an ineffective treatment generated results as positive as the 121 studies to date is estimated to be 1 in 27 million (p = 0.000000037).\n\n•Early treatment is most successful, with 100% of studies reporting a positive effect and an estimated reduction of 63% in the effect measured (death, hospitalization, etc.) using a random effects meta-analysis, RR 0.37 [0.29-0.48].\n\n•100% of Randomized Controlled Trials (RCTs) for early, PrEP, or PEP treatment report positive effects, the probability of this happening for an ineffective treatment is 0.002.\n\n•There is evidence of bias towards publishing negative results. Significantly more retrospective studies report negative results compared to prospective studies, p = 0.04.\n\n•Significantly more studies in North America report negative results compared to the rest of the world, p = 0.003.\n\nhttps://hcqmeta.com/\n\nRemember, if you are interested in getting a prescription for HCQ, it is very inexpensive, and this is what you need to do.\n\nObtained from a Twitter Tweet by Dr. Simone Gold, M.D.), quote: \"UPDATE: We have officially launched a resource to connect patients across the country with physicians & pharmacists who are HCQ knowledgeable!\n\nTo access:\nGo to: http://AFLDS.com\nClick on: HCQ\nClick on: your state of residence\nScroll down to: Speak to an MD",
"mediaType": "text/plain"
}
},
"id": "https://www.minds.com/api/activitypub/users/1152744141386424338/entities/urn:activity:1167843695489552384/activity"
},
{
"type": "Create",
"actor": "https://www.minds.com/api/activitypub/users/1152744141386424338",
"object": {
"type": "Note",
"id": "https://www.minds.com/api/activitypub/users/1152744141386424338/entities/urn:activity:1167841308270723072",
"attributedTo": "https://www.minds.com/api/activitypub/users/1152744141386424338",
"content": "Very interesting. <a href=\"https://wattsupwiththat.com/2020/10/26/remdesivir-for-covid-19-study-accidentally-proved-effectiveness-of-hydroxychloroquine/\" target=\"_blank\">https://wattsupwiththat.com/2020/10/26/remdesivir-for-covid-19-study-accidentally-proved-effectiveness-of-hydroxychloroquine/</a>",
"to": [
"https://www.w3.org/ns/activitystreams#Public"
],
"cc": [
"https://www.minds.com/api/activitypub/users/1152744141386424338/followers"
],
"tag": [],
"url": "https://www.minds.com/newsfeed/1167841308270723072",
"published": "2020-10-27T15:04:25+00:00",
"source": {
"content": "Very interesting. https://wattsupwiththat.com/2020/10/26/remdesivir-for-covid-19-study-accidentally-proved-effectiveness-of-hydroxychloroquine/",
"mediaType": "text/plain"
}
},
"id": "https://www.minds.com/api/activitypub/users/1152744141386424338/entities/urn:activity:1167841308270723072/activity"
},
{
"type": "Create",
"actor": "https://www.minds.com/api/activitypub/users/1152744141386424338",
"object": {
"type": "Note",
"id": "https://www.minds.com/api/activitypub/users/1152744141386424338/entities/urn:activity:1167841195213258752",
"attributedTo": "https://www.minds.com/api/activitypub/users/1152744141386424338",
"content": "Very interesting. <a href=\"https://wattsupwiththat.com/2020/10/26/remdesivir-for-covid-19-study-accidentally-proved-effectiveness-of-hydroxychloroquine/\" target=\"_blank\">https://wattsupwiththat.com/2020/10/26/remdesivir-for-covid-19-study-accidentally-proved-effectiveness-of-hydroxychloroquine/</a>",
"to": [
"https://www.w3.org/ns/activitystreams#Public"
],
"cc": [
"https://www.minds.com/api/activitypub/users/1152744141386424338/followers"
],
"tag": [],
"url": "https://www.minds.com/newsfeed/1167841195213258752",
"published": "2020-10-27T15:03:58+00:00",
"source": {
"content": "Very interesting. https://wattsupwiththat.com/2020/10/26/remdesivir-for-covid-19-study-accidentally-proved-effectiveness-of-hydroxychloroquine/",
"mediaType": "text/plain"
}
},
"id": "https://www.minds.com/api/activitypub/users/1152744141386424338/entities/urn:activity:1167841195213258752/activity"
},
{
"type": "Create",
"actor": "https://www.minds.com/api/activitypub/users/1152744141386424338",
"object": {
"type": "Note",
"id": "https://www.minds.com/api/activitypub/users/1152744141386424338/entities/urn:activity:1167577983364816896",
"attributedTo": "https://www.minds.com/api/activitypub/users/1152744141386424338",
"content": "Quote: \"Highlights<br />•<br />First COVID-19 outpatient study based on risk stratification and early antiviral treatment at the beginning of the disease<br /><br />•<br />Hydroxychloroquine at low dose in combination with zinc and azithromycin proved to be an effective therapeutic approach against COVID-19<br /><br />•<br />Significantly reduced hospitalization rates in the treatment group<br /><br />•<br />Reduced mortality rates in the treatment group\"<br /><br />Quote: \"4.1. POTENTIAL IMPLICATIONS FOR CLINICIANS AND POLICY MAKERS<br />Clinical experience from severely ill inpatients with pneumonia who were treated with high dose HCQ are not readily transferable to the outpatient setting with upper respiratory disease only. For outpatients with a median of only 4 days after onset of symptoms, COVID-19 represents a totally different disease and needs to be managed and treated differently [63]. A simple to perform outpatient risk stratification, as shown here, allows rapid treatment decisions and treatment with the triple therapy zinc, low dose HCQ, and azithromycin and may prevent a large number of hospitalizations and probably deaths during the SARS-CoV-2 pandemic. This might also help to avoid overwhelming of the health care systems.\"<br /><br /><a href=\"https://www.sciencedirect.com/science/article/pii/S0924857920304258\" target=\"_blank\">https://www.sciencedirect.com/science/article/pii/S0924857920304258</a>",
"to": [
"https://www.w3.org/ns/activitystreams#Public"
],
"cc": [
"https://www.minds.com/api/activitypub/users/1152744141386424338/followers"
],
"tag": [],
"url": "https://www.minds.com/newsfeed/1167577983364816896",
"published": "2020-10-26T21:38:03+00:00",
"source": {
"content": "Quote: \"Highlights\n•\nFirst COVID-19 outpatient study based on risk stratification and early antiviral treatment at the beginning of the disease\n\n•\nHydroxychloroquine at low dose in combination with zinc and azithromycin proved to be an effective therapeutic approach against COVID-19\n\n•\nSignificantly reduced hospitalization rates in the treatment group\n\n•\nReduced mortality rates in the treatment group\"\n\nQuote: \"4.1. POTENTIAL IMPLICATIONS FOR CLINICIANS AND POLICY MAKERS\nClinical experience from severely ill inpatients with pneumonia who were treated with high dose HCQ are not readily transferable to the outpatient setting with upper respiratory disease only. For outpatients with a median of only 4 days after onset of symptoms, COVID-19 represents a totally different disease and needs to be managed and treated differently [63]. A simple to perform outpatient risk stratification, as shown here, allows rapid treatment decisions and treatment with the triple therapy zinc, low dose HCQ, and azithromycin and may prevent a large number of hospitalizations and probably deaths during the SARS-CoV-2 pandemic. This might also help to avoid overwhelming of the health care systems.\"\n\nhttps://www.sciencedirect.com/science/article/pii/S0924857920304258",
"mediaType": "text/plain"
}
},
"id": "https://www.minds.com/api/activitypub/users/1152744141386424338/entities/urn:activity:1167577983364816896/activity"
},
{
"type": "Create",
"actor": "https://www.minds.com/api/activitypub/users/1152744141386424338",
"object": {
"type": "Note",
"id": "https://www.minds.com/api/activitypub/users/1152744141386424338/entities/urn:activity:1167577934687703040",
"attributedTo": "https://www.minds.com/api/activitypub/users/1152744141386424338",
"content": "Quote: \"Highlights<br />•<br />First COVID-19 outpatient study based on risk stratification and early antiviral treatment at the beginning of the disease<br /><br />•<br />Hydroxychloroquine at low dose in combination with zinc and azithromycin proved to be an effective therapeutic approach against COVID-19<br /><br />•<br />Significantly reduced hospitalization rates in the treatment group<br /><br />•<br />Reduced mortality rates in the treatment group\"<br /><br />Quote: \"4.1. POTENTIAL IMPLICATIONS FOR CLINICIANS AND POLICY MAKERS<br />Clinical experience from severely ill inpatients with pneumonia who were treated with high dose HCQ are not readily transferable to the outpatient setting with upper respiratory disease only. For outpatients with a median of only 4 days after onset of symptoms, COVID-19 represents a totally different disease and needs to be managed and treated differently [63]. A simple to perform outpatient risk stratification, as shown here, allows rapid treatment decisions and treatment with the triple therapy zinc, low dose HCQ, and azithromycin and may prevent a large number of hospitalizations and probably deaths during the SARS-CoV-2 pandemic. This might also help to avoid overwhelming of the health care systems.\"<br /><br /><a href=\"https://www.sciencedirect.com/science/article/pii/S0924857920304258\" target=\"_blank\">https://www.sciencedirect.com/science/article/pii/S0924857920304258</a>",
"to": [
"https://www.w3.org/ns/activitystreams#Public"
],
"cc": [
"https://www.minds.com/api/activitypub/users/1152744141386424338/followers"
],
"tag": [],
"url": "https://www.minds.com/newsfeed/1167577934687703040",
"published": "2020-10-26T21:37:52+00:00",
"source": {
"content": "Quote: \"Highlights\n•\nFirst COVID-19 outpatient study based on risk stratification and early antiviral treatment at the beginning of the disease\n\n•\nHydroxychloroquine at low dose in combination with zinc and azithromycin proved to be an effective therapeutic approach against COVID-19\n\n•\nSignificantly reduced hospitalization rates in the treatment group\n\n•\nReduced mortality rates in the treatment group\"\n\nQuote: \"4.1. POTENTIAL IMPLICATIONS FOR CLINICIANS AND POLICY MAKERS\nClinical experience from severely ill inpatients with pneumonia who were treated with high dose HCQ are not readily transferable to the outpatient setting with upper respiratory disease only. For outpatients with a median of only 4 days after onset of symptoms, COVID-19 represents a totally different disease and needs to be managed and treated differently [63]. A simple to perform outpatient risk stratification, as shown here, allows rapid treatment decisions and treatment with the triple therapy zinc, low dose HCQ, and azithromycin and may prevent a large number of hospitalizations and probably deaths during the SARS-CoV-2 pandemic. This might also help to avoid overwhelming of the health care systems.\"\n\nhttps://www.sciencedirect.com/science/article/pii/S0924857920304258",
"mediaType": "text/plain"
}
},
"id": "https://www.minds.com/api/activitypub/users/1152744141386424338/entities/urn:activity:1167577934687703040/activity"
},
{
"type": "Create",
"actor": "https://www.minds.com/api/activitypub/users/1152744141386424338",
"object": {
"type": "Note",
"id": "https://www.minds.com/api/activitypub/users/1152744141386424338/entities/urn:activity:1166519560566050816",
"attributedTo": "https://www.minds.com/api/activitypub/users/1152744141386424338",
"content": "<a href=\"https://covexit.com/national-institute-of-health-recommends-against-early-treatment-for-covid-19/\" target=\"_blank\">https://covexit.com/national-institute-of-health-recommends-against-early-treatment-for-covid-19/</a><br /><br />Whoever becomes President elect should fire everyone involved in this recommendation. It is criminally irresponsible and highly suspicious of corrupt influence by the biopharmaceutical industry. <br /><br />Remember, the FDA can not issue an emergency use authorization (rush to market) of a vaccine if any existing treatment is found to be effective. <br /><br />The main reasons Hydroxychloroquine and other patent-expired drugs are downplayed is because the vaccine makers can not apply for an Emergency Use Authorization if a treatment for the epidemic already exists. See <a href=\"https://www.fda.gov/regulatory-information/search-fda-guidance-documents/emergency-use-authorization-medical-products-and-related-authorities#declaration\" target=\"_blank\">https://www.fda.gov/regulatory-information/search-fda-guidance-documents/emergency-use-authorization-medical-products-and-related-authorities#declaration</a><br /><br />Quote: \"For FDA to issue an EUA, there must be no adequate, approved, and available alternative to the candidate product for diagnosing, preventing, or treating the disease or condition.\"<br /><br />Whatever the reason is, the establishment prefers profits over lives and politics over lives. At least in the US and other countries who are heavily corrupted by big medicine. They hate patent-expired drugs. Once the patent expires, the drug all of a sudden becomes dangerous!",
"to": [
"https://www.w3.org/ns/activitystreams#Public"
],
"cc": [
"https://www.minds.com/api/activitypub/users/1152744141386424338/followers"
],
"tag": [],
"url": "https://www.minds.com/newsfeed/1166519560566050816",
"published": "2020-10-23T23:32:16+00:00",
"source": {
"content": "https://covexit.com/national-institute-of-health-recommends-against-early-treatment-for-covid-19/\n\nWhoever becomes President elect should fire everyone involved in this recommendation. It is criminally irresponsible and highly suspicious of corrupt influence by the biopharmaceutical industry. \n\nRemember, the FDA can not issue an emergency use authorization (rush to market) of a vaccine if any existing treatment is found to be effective. \n\nThe main reasons Hydroxychloroquine and other patent-expired drugs are downplayed is because the vaccine makers can not apply for an Emergency Use Authorization if a treatment for the epidemic already exists. See https://www.fda.gov/regulatory-information/search-fda-guidance-documents/emergency-use-authorization-medical-products-and-related-authorities#declaration\n\nQuote: \"For FDA to issue an EUA, there must be no adequate, approved, and available alternative to the candidate product for diagnosing, preventing, or treating the disease or condition.\"\n\nWhatever the reason is, the establishment prefers profits over lives and politics over lives. At least in the US and other countries who are heavily corrupted by big medicine. They hate patent-expired drugs. Once the patent expires, the drug all of a sudden becomes dangerous!",
"mediaType": "text/plain"
}
},
"id": "https://www.minds.com/api/activitypub/users/1152744141386424338/entities/urn:activity:1166519560566050816/activity"
},
{
"type": "Create",
"actor": "https://www.minds.com/api/activitypub/users/1152744141386424338",
"object": {
"type": "Note",
"id": "https://www.minds.com/api/activitypub/users/1152744141386424338/entities/urn:activity:1166519051150090240",
"attributedTo": "https://www.minds.com/api/activitypub/users/1152744141386424338",
"content": "<a href=\"https://covexit.com/national-institute-of-health-recommends-against-early-treatment-for-covid-19/\" target=\"_blank\">https://covexit.com/national-institute-of-health-recommends-against-early-treatment-for-covid-19/</a><br /><br />Whoever becomes President elect should fire everyone involved in this recommendation. It is criminally irresponsible and highly suspicious of corrupt influence by the biopharmaceutical industry. <br /><br />Remember, the FDA can not issue an emergency use authorization (rush to market) of a vaccine if any existing treatment is found to be effective. <br /><br />The main reasons Hydroxychloroquine and other patent-expired drugs are downplayed is because the vaccine makers can not apply for an Emergency Use Authorization if a treatment for the epidemic already exists. See <a href=\"https://www.fda.gov/regulatory-information/search-fda-guidance-documents/emergency-use-authorization-medical-products-and-related-authorities#declaration\" target=\"_blank\">https://www.fda.gov/regulatory-information/search-fda-guidance-documents/emergency-use-authorization-medical-products-and-related-authorities#declaration</a><br /><br />Quote: \"For FDA to issue an EUA, there must be no adequate, approved, and available alternative to the candidate product for diagnosing, preventing, or treating the disease or condition.\"<br /><br />Whatever the reason is, the establishment prefers profits over lives and politics over lives. At least in the US and other countries who are heavily corrupted by big medicine. They hate patent-expired drugs. Once the patent expires, the drug all of a sudden becomes dangerous!",
"to": [
"https://www.w3.org/ns/activitystreams#Public"
],
"cc": [
"https://www.minds.com/api/activitypub/users/1152744141386424338/followers"
],
"tag": [],
"url": "https://www.minds.com/newsfeed/1166519051150090240",
"published": "2020-10-23T23:30:14+00:00",
"source": {
"content": "https://covexit.com/national-institute-of-health-recommends-against-early-treatment-for-covid-19/\n\nWhoever becomes President elect should fire everyone involved in this recommendation. It is criminally irresponsible and highly suspicious of corrupt influence by the biopharmaceutical industry. \n\nRemember, the FDA can not issue an emergency use authorization (rush to market) of a vaccine if any existing treatment is found to be effective. \n\nThe main reasons Hydroxychloroquine and other patent-expired drugs are downplayed is because the vaccine makers can not apply for an Emergency Use Authorization if a treatment for the epidemic already exists. See https://www.fda.gov/regulatory-information/search-fda-guidance-documents/emergency-use-authorization-medical-products-and-related-authorities#declaration\n\nQuote: \"For FDA to issue an EUA, there must be no adequate, approved, and available alternative to the candidate product for diagnosing, preventing, or treating the disease or condition.\"\n\nWhatever the reason is, the establishment prefers profits over lives and politics over lives. At least in the US and other countries who are heavily corrupted by big medicine. They hate patent-expired drugs. Once the patent expires, the drug all of a sudden becomes dangerous!",
"mediaType": "text/plain"
}
},
"id": "https://www.minds.com/api/activitypub/users/1152744141386424338/entities/urn:activity:1166519051150090240/activity"
}
],
"id": "https://www.minds.com/api/activitypub/users/1152744141386424338/outbox",
"partOf": "https://www.minds.com/api/activitypub/users/1152744141386424338/outboxoutbox"
}